Ali Rismani
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 12
- Blood groups and transfusion 3
- Genetics 14
- Chronic Lymphocytic Leukemia Research 11
- Co-authors
- Shirley D’Sa (23 shared papers)Kwee Yong (13 shared papers)Rakesh Popat (10 shared papers)Neil Rabin (10 shared papers)Νικόλαος Δικαίος (3 shared papers)Arash Latifoltojar (3 shared papers)Margaret Hall‐Craggs (3 shared papers)Magdalena Sokolska (3 shared papers)
- Journals
- Blood (13 papers)British Journal of Haematology (5 papers)British Journal of Cancer (1 paper)European Radiology (1 paper)HemaSphere (1 paper)
- Partner nations
- United KingdomNetherlandsCanada
In The Last Decade
Ali Rismani
24 papers receiving 228 citations
Peers
Comparison fields: 5 of 35
- Hematology 129
- Genetics 44
- Oncology 60
- Pathology and Forensic Medicine 28
- Orthopedics and Sports Medicine 12
Countries citing papers authored by Ali Rismani
This map shows the geographic impact of Ali Rismani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rismani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rismani more than expected).
Fields of papers citing papers by Ali Rismani
This network shows the impact of papers produced by Ali Rismani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rismani. The network helps show where Ali Rismani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Rismani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 59 | |
| 2 | 2016 | 47 | |
| 3 | 2020 | 45 | |
| 4 | 2017 | 21 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 8 | |
| 7 | 2016 | 7 | |
| 8 | 2022 | 5 | |
| 9 | 2020 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2015 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2016 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2016 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2021 | 1 |
About Ali Rismani
Ali Rismani is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 25 papers that have together received 230 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers), Protein Degradation and Inhibitors (5 papers), Cancer Treatment and Pharmacology (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Blood groups and transfusion (3 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Hematology (129 citations), Genetics (44 citations), Oncology (60 citations), Pathology and Forensic Medicine (28 citations) and Orthopedics and Sports Medicine (12 citations). Ali Rismani has collaborated with scholars based in United Kingdom, Netherlands and Canada. Frequent co-authors include Shirley D’Sa, Kwee Yong, Rakesh Popat, Neil Rabin, Νικόλαος Δικαίος, Arash Latifoltojar, Margaret Hall‐Craggs, Magdalena Sokolska, Charalampia Kyriakou and Alan Bainbridge. Their work appears in journals such as Blood, British Journal of Haematology, British Journal of Cancer, European Radiology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.